Description
A potent inhibitor of GCP II/NAALADase (Ki = 98 pM for release of glutamate from the NAALADase peptide substrate NAAG); selective for GCP II/NAALADase over a panel of 100 receptors, transporters, ion channels, and enzymes at a concentration of 10 μM; neuroprotective against hypoxia (EC50 = 8.4 μM) in neuron-enriched primary cultures from rat embryo cerebellum; reduces neuronal cell death induced by middle cerebral artery occlusion in rats; blocks the conditioned place preference response to cocaine in male rats (100 mg/kg); reduces the number of flinches induced by formalin injection into the footpad of mice (10 μg per animal); decreases severity and delays onset of EAE in mice,
Formal name: 2-(phosphonomethyl)-pentanedioic acid
Synonyms: 2-PMPA
Molecular weight: 226.1
CAS: 173039-10-6
Purity: ≥95%
Formulation: A crystalline solid
Product Type|Biochemicals|Small Molecule Inhibitors|Peptidases & Proteases||Research Area|Immunology & Inflammation|Autoimmunity||Research Area|Neuroscience|Behavioral Neuroscience|Addiction Research||Research Area|Neuroscience|Neuroprotection||Research Area|Neuroscience|Pain Research